Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03707275 · ClinicalTrials.gov registry record · NA

Personalized Voice Activated Wellness Assistants for Patients With Heart Failure

A NA study, sponsored by Medstar Health Research Institute.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03707275 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03707275, a NA study, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The Alexa+ Study will compare the use of the Amazon Echo Dot with Alexa voice technology in patients with chronic heart failure to those receiving standard of care heart failure management on changes in health and patient-centered outcomes.

Interventions

  • OTHER Standard of Care Arm
  • DEVICE Alexa+

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-12-10
Est. Completion 2019-10-31
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT03707275

The ClinicalTrials.gov registry entry for NCT03707275 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard of Care Arm is the first listed.

NCT03707275 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03707275 about?

NCT03707275 is a clinical study titled "Personalized Voice Activated Wellness Assistants for Patients With Heart Failure". The Alexa+ Study will compare the use of the Amazon Echo Dot with Alexa voice technology in patients with chronic heart failure to those receiving standard of care heart failure management on changes in health and patient-centered outcomes.

What is the current status of trial NCT03707275?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-12-10. Estimated completion is 2019-10-31.

What interventions are being tested in trial NCT03707275?

The interventions under investigation include: Standard of Care Arm (OTHER), Alexa+ (DEVICE).

Who is sponsoring clinical trial NCT03707275?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.